Alembic gains USFDA final approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg Read more
Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets Read more
AstraZeneca India receives CDSCO approval for Durvalumab for specified additional indication Read more